<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00837642</url>
  </required_header>
  <id_info>
    <org_study_id>35/07</org_study_id>
    <nct_id>NCT00837642</nct_id>
  </id_info>
  <brief_title>Vascular Dysfunction in Offspring of Assisted Reproduction Technologies</brief_title>
  <official_title>Vascular Dysfunction in Offspring of Assisted Reproduction Technologies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Lausanne Hospitals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prevalence of infertility has been estimated at 9% worldwide. The steadily increasing use
      of assisted reproductive technologies (ART) has allowed millions of infertile couples to have
      children. These children make up for 1 to 4% of the population in developed countries. ART
      involves the manipulation of early embryos at a time when they may be particularly vulnerable
      to external disturbances. In line with this concept, studies in mice suggest that ART alters
      the activity of enzymes involved in the regulation of metabolic and cardiovascular
      homeostasis. Alternatively, infertility itself or the drugs used to stimulate ovulation may
      have adverse effects on the outcome of the offspring. The safety of ART for long-term health
      is, therefore, of utmost importance. Among the potential long-term consequences of ART,
      cardiovascular disease may represent an important candidate, but there is no information.

      Investigators show that, children born after in vitro fertilization (IVF) present systemic
      and pulmonary vascular dysfunction at high-altitude when compared to age- and sex-matched
      control subjects. A 5 years follow-up study shows that premature vascular aegieng persist and
      evolve to arterial hypertension. Arterial hypertension may induce cardiac dysfunction.

      Therefore, the major goal of this proposal is to assess cardiac function in apparently
      healthy participants born after ART.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac function</measure>
    <time_frame>1 year</time_frame>
    <description>Ejection fraction [%]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Left ventricular musce mass</measure>
    <time_frame>1 year</time_frame>
    <description>Left ventricular muscle mass [g/m2]</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>ART (Assited reproductive technologies)</arm_group_label>
    <description>In participants born after IVF will be performed a transthoracic echocardiography</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>In participants naturally conceived will be performed a transthoracic echocardiography</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Transthoracic echocardiography</intervention_name>
    <description>Full transthoracic echocardiography will be performed.</description>
    <arm_group_label>ART (Assited reproductive technologies)</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All the partcicipants that have been participated in our previous studies will be asked to
        take part in this new study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Offspring of ART

          -  Healthy

          -  Born at term

        Exclusion Criteria:

          -  Cardio-pulmonary malformations

          -  Neuro-muscular malformations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emrush Rexhaj, PD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Bern, Cardiology, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Urs Scherrer, Prof</last_name>
    <phone>+4131 632 2111</phone>
    <email>Urs.Scherrer2@insel.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emrush Rexhaj, PD</last_name>
    <phone>+4131 632 2111</phone>
    <email>emrush.rexhaj@insel.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Bern</city>
        <state>BE</state>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emrush Rexhaj, PD</last_name>
      <phone>+4131 632 21 11</phone>
      <email>emrush.rexhaj@insel.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 4, 2009</study_first_submitted>
  <study_first_submitted_qc>February 4, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2009</study_first_posted>
  <last_update_submitted>February 19, 2020</last_update_submitted>
  <last_update_submitted_qc>February 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne Hospitals</investigator_affiliation>
    <investigator_full_name>Urs Scherrer</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Vascular function in offspring of ART</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

